TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Fujirebio Diagnostics AB
Closing information (x1000 NOK)
Closing information | 2023/03 (consolidated) | 2022/03 (consolidated) | 2021/03 (consolidated) |
Turnover | 246,685 | 244,614 | |
Financial expenses | 441 | 28,568 | |
Earnings before taxes | 129,675 | 98,340 | |
EBITDA | 134,665 | 131,360 | |
Total assets | 572,462 | 454,713 | |
Current assets | 276,319 | 389,193 | |
Current liabilities | 59,135 | 27,626 | |
Equity capital | 507,107 | 421,909 | |
- share capital | 596 | 627 | |
Employees (average) | 86 | 75 | 71 |
Financial ratios
Fiscal year | 2023/03 (consolidated) | 2022/03 (consolidated) | 2021/03 (consolidated) |
Solvency | 88.6% | 92.8% | |
Turnover per employee | 3,289 | 3,445 | |
Profit as a percentage of turnover | 52.6% | 40.2% | |
Return on assets (ROA) | 22.7% | 27.9% | |
Current ratio | 467.3% | 1408.8% | |
Return on equity (ROE) | 25.6% | 23.3% | |
Change turnover | 13,874 | -24,665 | |
Change turnover % | 17% | 6% | -9% |
Chg. No. of employees | 11 | 4 | 4 |
Chg. No. of employees % | 15% | 6% | 6% |
Total value of public sale
Fiscal year | 2023/03 (consolidated) | 2022/03 (consolidated) | 2021/03 (consolidated) |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.